Skip to main content
Clinical Trials/ChiCTR2100045413
ChiCTR2100045413Active, not recruitingNot Applicable

老年患者围术期 HBD-2 和 LXA4 对术后肺部并发症的影响及其与预后的关系

国家重点专项计划1 site in 1 country200 target enrollmentStarted: May 1, 2021Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
β-防御素 2

Study Overview

Brief Summary

1、研究老年患者术后肺部并发症的发生率; 2、探究 LXA4 及 HBD-2 对术后肺部并发症的影响。

Study Design

Study Type
观察性研究
Primary Purpose
连续入组
Masking
N/a

Eligibility Criteria

Ages
65 to — (—)
Sex
All

Inclusion Criteria

  • 2.择期在全身麻醉下接受外科手术。

Exclusion Criteria

  • 1.患者术前 24 小时入 ICU;
  • 2.患者及家属拒绝入组;
  • 3.患者因严重痴呆、语言障碍、听力或视觉严重受损等无法沟通。

Arms & Interventions

连续入组

Outcomes

Primary Outcomes

β-防御素 2

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
国家重点专项计划

Study Sites (1)

Loading locations...

Similar Trials